Literature DB >> 22223542

Implications of protein post-translational modifications in IBD.

Stefan F Ehrentraut1, Sean P Colgan.   

Abstract

In recent years our understanding of the pathogenesis of inflammatory bowel disease (IBD) has greatly increased. Hallmarks of IBD include loss of intestinal barrier function, increased cytokine production, and failed resolution of tissue damage. Lasting treatments are still lacking and, therefore, a better understanding of the underlying molecular mechanisms is necessary to design novel therapeutic approaches. Apart from transcriptional and posttranscriptional regulation of relevant genes, mammals have evolved a complex and efficient series of mechanisms to rapidly modify newly made proteins for the purposes of signaling and adaptation. These posttranslational protein modifications include, among others, phosphorylation, hydroxylation, neddylation, and cytokine cleavage by the inflammasome. This review focuses on our current understanding of posttranslational protein modifications with a particular focus on their relevance to IBD pathogenesis.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223542      PMCID: PMC3378042          DOI: 10.1002/ibd.22859

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  117 in total

1.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.

Authors:  Christian Bauer; Peter Duewell; Christine Mayer; Hans Anton Lehr; Katherine A Fitzgerald; Marc Dauer; Jurg Tschopp; Stefan Endres; Eicke Latz; Max Schnurr
Journal:  Gut       Date:  2010-05-04       Impact factor: 23.059

Review 2.  Oxygen homeostasis.

Authors:  Gregg L Semenza
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 May-Jun

3.  Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanism.

Authors:  Anastasia Mashukova; Flavia A Wald; Pedro J Salas
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

4.  Recent insights into the genetics of inflammatory bowel disease.

Authors:  Judy H Cho; Steven R Brant
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

5.  IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation.

Authors:  Mohammad Hasan Zaki; Peter Vogel; Mathilde Body-Malapel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

Review 6.  Using small molecule GSK3β inhibitors to treat inflammation.

Authors:  G Klamer; E Song; K-H Ko; T A O'Brien; A Dolnikov
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

7.  Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function.

Authors:  Murtaza M Tambuwala; Eoin P Cummins; Colin R Lenihan; Judit Kiss; Markus Stauch; Carsten C Scholz; Peter Fraisl; Felix Lasitschka; Martin Mollenhauer; Sean P Saunders; Patrick H Maxwell; Peter Carmeliet; Padraic G Fallon; Martin Schneider; Cormac T Taylor
Journal:  Gastroenterology       Date:  2010-06-30       Impact factor: 22.682

Review 8.  Hypoxia and inflammation.

Authors:  Holger K Eltzschig; Peter Carmeliet
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

9.  Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.

Authors:  Pieter Hindryckx; Martine De Vos; Peggy Jacques; Liesbeth Ferdinande; Harald Peeters; Kim Olievier; Sara Bogaert; Brigitta Brinkman; Peter Vandenabeele; Dirk Elewaut; Debby Laukens
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

10.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Authors:  Andre Franke; Dermot P B McGovern; Jeffrey C Barrett; Kai Wang; Graham L Radford-Smith; Tariq Ahmad; Charlie W Lees; Tobias Balschun; James Lee; Rebecca Roberts; Carl A Anderson; Joshua C Bis; Suzanne Bumpstead; David Ellinghaus; Eleonora M Festen; Michel Georges; Todd Green; Talin Haritunians; Luke Jostins; Anna Latiano; Christopher G Mathew; Grant W Montgomery; Natalie J Prescott; Soumya Raychaudhuri; Jerome I Rotter; Philip Schumm; Yashoda Sharma; Lisa A Simms; Kent D Taylor; David Whiteman; Cisca Wijmenga; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Albert Cohen; Jean-Frederick Colombel; Mario Cottone; Laura Stronati; Ted Denson; Martine De Vos; Renata D'Inca; Marla Dubinsky; Cathryn Edwards; Tim Florin; Denis Franchimont; Richard Gearry; Jürgen Glas; Andre Van Gossum; Stephen L Guthery; Jonas Halfvarson; Hein W Verspaget; Jean-Pierre Hugot; Amir Karban; Debby Laukens; Ian Lawrance; Marc Lemann; Arie Levine; Cecile Libioulle; Edouard Louis; Craig Mowat; William Newman; Julián Panés; Anne Phillips; Deborah D Proctor; Miguel Regueiro; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Frank Seibold; A Hillary Steinhart; Pieter C F Stokkers; Leif Torkvist; Gerd Kullak-Ublick; David Wilson; Thomas Walters; Stephan R Targan; Steven R Brant; John D Rioux; Mauro D'Amato; Rinse K Weersma; Subra Kugathasan; Anne M Griffiths; John C Mansfield; Severine Vermeire; Richard H Duerr; Mark S Silverberg; Jack Satsangi; Stefan Schreiber; Judy H Cho; Vito Annese; Hakon Hakonarson; Mark J Daly; Miles Parkes
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

View more
  10 in total

1.  Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses.

Authors:  Valerie F Curtis; Stefan F Ehrentraut; Eric L Campbell; Louise E Glover; Amanda Bayless; Caleb J Kelly; Douglas J Kominsky; Sean P Colgan
Journal:  FASEB J       Date:  2014-10-17       Impact factor: 5.191

Review 2.  Emerging role of protein modification in inflammatory bowel disease.

Authors:  Gaoying Wang; Jintao Yuan; Ji Luo; Dickson Kofi Wiredu Ocansey; Xu Zhang; Hui Qian; Wenrong Xu; Fei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

3.  Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response.

Authors:  Stefan F Ehrentraut; Douglas J Kominsky; Louise E Glover; Eric L Campbell; Caleb J Kelly; Brittelle E Bowers; Amanda J Bayless; Sean P Colgan
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

Review 4.  Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.

Authors:  Tue Bennike; Svend Birkelund; Allan Stensballe; Vibeke Andersen
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.

Authors:  Tue Bjerg Bennike; Thomas Gelsing Carlsen; Torkell Ellingsen; Ole Kristian Bonderup; Henning Glerup; Martin Bøgsted; Gunna Christiansen; Svend Birkelund; Allan Stensballe; Vibeke Andersen
Journal:  Inflamm Bowel Dis       Date:  2015-09       Impact factor: 5.325

6.  Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins.

Authors:  Aaron Lerner; Rustam Aminov; Torsten Matthias
Journal:  Front Microbiol       Date:  2016-02-05       Impact factor: 5.640

7.  SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease.

Authors:  Salman Ahmad Mustfa; Mukesh Singh; Aamir Suhail; Gayatree Mohapatra; Smriti Verma; Debangana Chakravorty; Sarika Rana; Ritika Rampal; Atika Dhar; Sudipto Saha; Vineet Ahuja; C V Srikanth
Journal:  Open Biol       Date:  2017-06       Impact factor: 6.411

8.  Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation.

Authors:  Mengmeng Cheng; Shurong Hu; Zhengting Wang; Yaofei Pei; Rong Fan; Xiqiang Liu; Lei Wang; Jie Zhou; Sichang Zheng; Tianyu Zhang; Yun Lin; Maochen Zhang; Ran Tao; Jie Zhong
Journal:  Oncotarget       Date:  2016-06-14

9.  Perturbation of neddylation-dependent NF-κB responses in the intestinal epithelium drives apoptosis and inhibits resolution of mucosal inflammation.

Authors:  Stefan F Ehrentraut; Valerie F Curtis; Ruth X Wang; Bejan J Saeedi; Heidi Ehrentraut; Joseph C Onyiah; Caleb J Kelly; Eric L Campbell; Louise E Glover; Douglas J Kominsky; Sean P Colgan
Journal:  Mol Biol Cell       Date:  2016-09-28       Impact factor: 4.138

10.  Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis.

Authors:  Gabriela Fonseca Camarillo; Emilio Iturriaga Goyon; Rafael Barreto Zuñiga; Lucero Adriana Salazar Salas; Ana Elena Peredo Escárcega; Jesús K Yamamoto-Furusho
Journal:  Mediators Inflamm       Date:  2020-01-18       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.